About this trial
This multicenter, ambispective cohort study establishes a comprehensive multiomics biobank from five stroke centers, encompassing thrombi, intracranial blood, peripheral arterial/venous blood, and clinical-laboratory-imaging-follow-up data from patients with acute ischemic stroke with large vessel occlusion (AIS-LVO).
Eligibility criteria
Qualifiers
Age over 18 years.
Patients with intracranial and extracranial large vessel occlusion ischemic stroke confirmed by cerebrovascular angiography.
Availability of complete clinical and follow-up information required for the study.
Availability of blood and/or thrombus biological samples.
Disqualifiers
Patients for whom biological samples cannot be obtained;
Patients or their family members who refuse to sign the informed consent form.
Trial design
Treatments tested in this trial
- Not applicable- observational study
Treatment groups
Sponsors and collaborators
First Affiliated Hospital of Wannan Medical College
Lead sponsor
Beijing Tiantan Hospital
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
Baotou Central Hospital
Collaborator
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Collaborator